class such as farampator and CX-717 are compared to. AMPA receptor positive allosteric modulator Danysz W (July 2002). "CX-516 Cortex pharmaceuticals"...
3 KB (153 words) - 11:49, 7 June 2024
allosteric modulators: Aniracetam Cyclothiazide CX-516 CX-546 CX-614 Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942 Diazoxide Hydrochlorothiazide (HCTZ)...
70 KB (7,818 words) - 15:31, 31 August 2024
development of newer compounds such as CX-614 and CX-717 with superior properties over the earlier drugs. CX-546 itself has been investigated for other...
4 KB (279 words) - 12:33, 14 July 2024
Methylhexaneamine Octodrine Propylhexedrine Tuaminoheptane Ampakines CX-516 CX-546 CX-614 CX-691 CX-717 IDRA-21 LY-404,187 LY-503,430 Nooglutyl Org 26576 PEPA S-18986...
20 KB (1,745 words) - 22:56, 15 August 2024
Methylhexaneamine Octodrine Propylhexedrine Tuaminoheptane Ampakines CX-516 CX-546 CX-614 CX-691 CX-717 IDRA-21 LY-404,187 LY-503,430 Nooglutyl Org 26576 PEPA S-18986...
18 KB (1,828 words) - 14:23, 6 September 2024
the RespireRx drug development program are CX-516 (Ampalex), CX-546, CX-614, CX-691 (farampator), and CX-717. ORG-26576 was developed by RespireRx but...
9 KB (928 words) - 16:55, 9 June 2024
farampator (CX-691, ORG-24481, SCH-900460), CX-717, CX-929, CX-1501, tulrampator (S-47445, CX-1632), CX-1739, CX-1796, CX-1837, CX-1942, CX-2007, CX-2076, ORG-26576...
12 KB (1,257 words) - 04:21, 5 September 2024
Methylhexaneamine Octodrine Propylhexedrine Tuaminoheptane Ampakines CX-516 CX-546 CX-614 CX-691 CX-717 IDRA-21 LY-404,187 LY-503,430 Nooglutyl Org 26576 PEPA S-18986...
76 KB (9,321 words) - 00:04, 2 September 2024
allosteric modulators: Aniracetam Cyclothiazide CX-516 CX-546 CX-614 Farampator (CX-691, ORG-24448) CX-717 CX-1739 CX-1942 Diazoxide Hydrochlorothiazide (HCTZ)...
24 KB (2,346 words) - 05:23, 5 September 2024